# Boston Scientific Corporation (BSX): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Boston Scientific Corporation (BSX) is 51/100, ranked against 24,000+ stocks in 35 markets (Quality 67, Value 52, Momentum 25, each scored against its sector).

- StockRank: 51/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 67, Value 52, Momentum 25: each a 0-100 percentile within Healthcare.
- Position: #13,167 overall, #1,199 in Healthcare.
- Listing: United States, NYQ; Healthcare / Medical Devices.
- Last close: 45.69 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors bought USD 10.0M.
- Buybacks, last 180 days: the company bought back USD 2.0B on 1 day.

Source: https://moatmap.ai/stock/BSX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker